先進的イメージング技術が自己免疫疾患のメカニズムを解明(Advanced Imaging Reveals Mechanisms That Cause Autoimmune Disease)

ad

2025-04-08 カリフォルニア大学サンディエゴ校(UCSD)

カリフォルニア大学サンディエゴ校(UC San Diego)の生物科学部の研究者たちは、重症筋無力症(myasthenia gravis)の発症メカニズムを解明するため、先進的なイメージング技術を用いて新たな知見を得ました。重症筋無力症は、神経と筋肉の間のコミュニケーション障害によって引き起こされる自己免疫疾患で、まぶたの下垂、表情筋の衰え、全身の筋力低下などの症状を特徴とします。研究チームは、免疫系が誤って自己のアセチルコリン受容体を攻撃する過程を詳細に観察し、自己抗体がシナプス後膜の構造と機能に与える影響を明らかにしました。この研究は、重症筋無力症の新しい治療法開発に寄与する可能性があります。

<関連情報>

筋アセチルコリン受容体の構造から解明された自己免疫メカニズム Autoimmune mechanisms elucidated through muscle acetylcholine receptor structures

Huanhuan Li∙ Minh C. Pham∙ Jinfeng Teng∙ Kevin C. O’Connor∙ Colleen M. Noviello∙ Ryan E. Hibbs
Cell  Published:April 8, 2025
DOI:https://doi.org/10.1016/j.cell.2025.03.004

Graphical abstract

先進的イメージング技術が自己免疫疾患のメカニズムを解明(Advanced Imaging Reveals Mechanisms That Cause Autoimmune Disease)

Highlights

  • Human adult muscle ACh receptor structures in resting and desensitized states
  • Receptor structures with MG autoantibodies reveal binding heterogeneity
  • Epitope mapping for mechanistically distinct pathogenic MG autoantibodies
  • Structural and functional elucidation of different inhibitory mechanisms in MG

Summary

Skeletal muscle contraction is triggered by acetylcholine (ACh) binding to its ionotropic receptors (AChRs) at neuromuscular junctions. In myasthenia gravis (MG), autoantibodies target AChRs, disrupting neurotransmission and causing muscle weakness. While treatments exist, variable patient responses suggest pathogenic heterogeneity. Progress in understanding the molecular basis of MG has been limited by the absence of structures of intact human muscle AChRs. Here, we present high-resolution cryoelectron microscopy (cryo-EM) structures of the human adult AChR in different functional states. Using six MG patient-derived monoclonal antibodies, we mapped distinct epitopes involved in diverse pathogenic mechanisms, including receptor blockade, internalization, and complement activation. Electrophysiological and binding assays revealed how these autoantibodies directly inhibit AChR channel activation. These findings provide critical insights into MG immunopathogenesis, uncovering unrecognized antibody epitope diversity and modes of receptor inhibition, and provide a framework for developing personalized therapies targeting antibody-mediated autoimmune disorders.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました